RDNT
RadNet, Inc. NASDAQ Listed Jan 3, 1997$53.74
+1.74%
vs $52.82
Mkt Cap $4.0B
52w Low $51.87
5.7% of range
52w High $84.48
50d MA $55.96
200d MA $68.33
P/E (TTM)
-215.0x
EV/EBITDA
17.9x
P/B
3.0x
Debt/Equity
1.7x
ROE
-1.7%
P/FCF
47.2x
RSI (14)
45.60
ATR (14)
$2.76
Beta
1.53
50d MA
$55.96
200d MA
$68.33
Avg Volume
906.6K
RadNet, Inc., together with its subsidiaries, provides outpatient diagnostic imaging services in the United States. Its services include magnetic resonance imaging, computed tomography, positron emission tomography, nuclear medicine, mammography, ultrasound, diagnostic radiology, fluoroscopy, and other related procedures, as well as multi-modality imaging services. The company also develops and sells computerized systems for the diagnostic imaging industry, including picture archiving communications systems and related services; and develops and deploys AI suites to enhance radiologist interpretation of images in the field of mammography, as well as AI solutions for lung and prostate cancer. As of December 31, 2021, it owned and managed 347 centers in Arizona, California, Delaware, Florida, Maryland, New Jersey, and New York. The company was founded in 1981 and is headquartered in Los Angeles, California.
1508, 1510 and 1516 Cotner Avenue · Los Angeles, CA 90025-3303 · US
| Date | Time | Est | Rptd | Surp | Base | Gap% | D1% | D2% | D3% | D4% | D5% | Guide ▲★ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| May 11, 2026 | AMC | 0.19 | -0.28 | -247.4% | 55.90 | -2.5% | +0.2% | -5.4% | +0.8% | -1.9% | +3.4% | — |
| Mar 2, 2026 | AMC | 0.19 | 0.23 | +21.1% | 75.22 | -3.0% | -3.5% | -1.7% | -6.5% | -9.0% | +2.7% | — |
| Nov 9, 2025 | AMC | 0.22 | 0.20 | -10.3% | — | — | — | — | — | — | — | — |
| Aug 10, 2025 | AMC | 0.17 | 0.31 | +82.4% | — | — | — | — | — | — | — | — |
| May 11, 2025 | AMC | -0.17 | -0.35 | -105.9% | — | — | — | — | — | — | — | — |
| Feb 27, 2025 | AMC | 0.21 | 0.22 | +4.8% | 57.60 | -13.2% | -3.7% | -8.3% | +1.9% | +2.4% | -2.8% | — |
| Nov 10, 2024 | AMC | 0.14 | 0.18 | +32.5% | — | — | — | — | — | — | — | — |
| Aug 7, 2024 | AMC | 0.16 | 0.16 | +0.0% | 56.89 | +1.5% | +8.4% | +1.9% | -1.9% | +2.7% | -1.0% | — |
| May 8, 2024 | AMC | -0.09 | 0.07 | +177.8% | 50.63 | +0.8% | +5.8% | +3.1% | +0.9% | +1.8% | +2.7% | — |
| Feb 29, 2024 | AMC | 0.11 | 0.20 | +81.8% | 37.86 | +5.7% | +17.1% | +5.6% | +1.3% | +2.3% | +0.1% | — |
| Nov 8, 2023 | AMC | 0.06 | 0.14 | +133.3% | 28.72 | +3.3% | +2.6% | -1.0% | -1.3% | +9.7% | +2.4% | — |
| Aug 8, 2023 | AMC | 0.07 | 0.24 | +242.9% | 31.72 | +0.6% | -0.7% | +1.3% | -1.3% | +0.5% | +1.3% | — |
| May 9, 2023 | AMC | -0.07 | -0.08 | -14.3% | 28.56 | +1.1% | -1.1% | -4.4% | -0.1% | +2.7% | -0.3% | — |
| Date | Firm | Action | Grade | Target | Base | Open | Gap% | D1% | D2% | D3% | D4% | D5% |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Apr 21 | Barclays | Maintains | Overweight → Overweight | — | $57.85 | $57.83 | -0.0% | -0.6% | +0.6% | -2.4% | +2.1% | +0.2% |
| Dec 1 | B. Riley Securities | Maintains | Buy → Buy | — | $82.79 | $82.25 | -0.7% | -3.4% | -1.5% | +0.8% | +2.0% | -3.1% |
| Nov 13 | Barclays | Maintains | Overweight → Overweight | — | $74.45 | $74.05 | -0.5% | -1.3% | +2.3% | +2.5% | +2.8% | +1.4% |
| Nov 12 | Truist | Maintains | Buy → Buy | — | $78.50 | $78.45 | -0.1% | -5.2% | -1.3% | +2.3% | +2.5% | +2.8% |
| Sep 3 | Barclays | Maintains | Overweight → Overweight | — | $70.31 | $71.44 | +1.6% | +0.9% | +1.9% | -1.2% | +0.8% | +1.5% |
| Sep 3 | Truist | Maintains | Buy → Buy | — | $70.31 | $71.44 | +1.6% | +0.9% | +1.9% | -1.2% | +0.8% | +1.5% |
| Aug 13 | Raymond James | Maintains | Strong Buy → Strong Buy | — | $63.60 | $64.45 | +1.3% | +7.6% | +0.5% | -1.9% | -1.7% | +2.5% |
| Apr 11 | Truist | Maintains | Buy → Buy | — | $53.00 | $52.75 | -0.5% | +0.8% | -0.1% | -0.5% | -4.8% | -1.5% |
| Mar 24 | Barclays | Maintains | Overweight → Overweight | — | $49.25 | $49.52 | +0.5% | +5.2% | -2.2% | +0.0% | -0.1% | -2.4% |
| Mar 5 | Raymond James | Upgrade | Outperform → Strong Buy | — | $51.83 | $52.25 | +0.8% | +2.4% | -2.8% | -2.5% | -4.5% | +2.5% |
| Jan 22 | Barclays | Maintains | Overweight → Overweight | — | $60.19 | $59.71 | -0.8% | +5.9% | +1.9% | -1.3% | -1.2% | +4.2% |
| Jan 22 | Truist | Maintains | Buy → Buy | — | $60.19 | $59.71 | -0.8% | +5.9% | +1.9% | -1.3% | -1.2% | +4.2% |
| Jan 15 | Jefferies | Maintains | Buy → Buy | — | $65.65 | $66.61 | +1.5% | -6.0% | -1.4% | -1.7% | +0.6% | +5.9% |
| Dec 5 | Jefferies | Maintains | Buy → Buy | — | $80.86 | $79.95 | -1.1% | -2.1% | +3.1% | -3.3% | +0.0% | +2.1% |
| Dec 4 | Barclays | Maintains | Overweight → Overweight | — | $80.64 | $81.29 | +0.8% | +0.3% | -2.1% | +3.1% | -3.3% | +0.0% |
| Nov 29 | Truist | Maintains | Buy → Buy | — | $82.49 | $84.24 | +2.1% | -0.9% | +1.3% | -2.7% | +0.3% | -2.1% |
| Sep 23 | Truist | Maintains | Buy → Buy | — | $69.34 | $70.00 | +1.0% | +2.5% | -1.8% | +1.5% | -2.6% | +0.4% |
| Sep 19 | Jefferies | Maintains | Buy → Buy | — | $67.11 | $69.32 | +3.3% | +3.8% | -0.4% | +2.5% | -1.8% | +1.5% |
| Sep 6 | Barclays | Upgrade | Equal Weight → Overweight | — | $63.19 | $65.79 | +4.1% | -1.2% | -2.5% | -0.8% | +3.2% | +7.9% |
| Aug 8 | Barclays | Maintains | Equal Weight → Equal Weight | — | $56.89 | $57.76 | +1.5% | +8.4% | +1.9% | -1.9% | +2.7% | -1.0% |
| Jul 15 | Truist | Maintains | Buy → Buy | — | $61.41 | $62.50 | +1.8% | +2.1% | +3.9% | -4.3% | -3.0% | +2.5% |
| Jul 11 | Jefferies | Maintains | Buy → Buy | — | $56.22 | $58.21 | +3.5% | +6.4% | +2.6% | +2.1% | +3.9% | -4.3% |
| Jul 10 | Barclays | Maintains | Equal Weight → Equal Weight | — | $56.69 | $57.15 | +0.8% | -0.8% | +6.4% | +2.6% | +2.1% | +3.9% |
| May 15 | Truist | Maintains | Buy → Buy | — | $56.73 | $57.38 | +1.1% | +2.7% | -1.1% | -0.2% | +1.8% | -0.4% |
| May 10 | Raymond James | Maintains | Outperform → Outperform | — | $53.57 | $53.82 | +0.5% | +3.1% | +0.9% | +1.8% | +2.7% | -1.1% |
| Mar 28 | Truist | Maintains | Buy → Buy | — | $48.49 | $48.91 | +0.9% | +0.4% | -1.1% | -0.2% | +0.1% | -0.3% |
| Mar 22 | Jefferies | Maintains | Buy → Buy | — | $47.17 | $47.25 | +0.2% | +1.8% | -2.1% | +2.7% | +0.4% | +0.4% |
| Mar 4 | Truist | Maintains | Buy → Buy | — | $44.35 | $44.95 | +1.4% | +5.6% | +1.3% | +2.3% | +0.1% | -4.2% |
| Dec 8 | Truist | Maintains | Buy → Buy | — | $36.02 | $36.66 | +1.8% | +0.6% | -0.4% | +0.7% | +2.3% | -0.5% |
| Jun 26 | Raymond James | Maintains | Outperform → Outperform | — | $33.44 | $33.36 | -0.2% | -2.0% | +0.9% | +0.6% | -0.8% | -1.1% |
| May 10 | Raymond James | Maintains | Outperform → Outperform | — | $28.56 | $28.87 | +1.1% | -1.1% | -4.4% | -0.1% | +2.7% | -0.3% |
| Mar 31 | CJS Securities | Maintains | Outperform → Outperform | — | $24.48 | $24.63 | +0.6% | +2.2% | +0.6% | -0.7% | +0.3% | +3.8% |
| Mar 3 | Raymond James | Upgrade | Market Perform → Outperform | — | $23.81 | $25.17 | +5.7% | +5.3% | -2.8% | +0.7% | -0.3% | -3.0% |
| Aug 12 | Raymond James | Downgrade | Outperform → Market Perform | — | $33.35 | $32.50 | -2.5% | -4.3% | -4.2% | +8.6% | -4.3% | -1.4% |
| Aug 12 | Barclays | Maintains | Overweight → Overweight | — | $33.35 | $32.50 | -2.5% | -4.3% | -4.2% | +8.6% | -4.3% | -1.4% |
| Mar 9 | Raymond James | Maintains | Outperform → Outperform | — | $22.07 | $23.00 | +4.2% | +5.0% | -0.9% | +2.6% | +1.3% | +0.5% |
| Aug 11 | Raymond James | Maintains | Outperform → Outperform | — | $17.35 | $17.54 | +1.1% | +1.0% | +1.7% | -0.9% | -2.4% | -1.9% |
| May 26 | Sidoti & Co. | Maintains | Buy → Buy | — | $17.21 | $18.00 | +4.6% | +3.2% | +3.7% | -4.4% | -3.2% | -0.6% |
| Feb 21 | Sidoti & Co. | Maintains | Buy → Buy | — | $22.94 | $23.02 | +0.3% | +0.7% | -0.7% | -4.7% | +0.8% | -4.4% |
| Dec 2 | Sidoti & Co. | Maintains | Buy → Buy | — | $19.16 | $19.42 | +1.4% | +3.4% | +2.4% | -4.2% | +0.8% | +0.4% |
| Nov 13 | Sidoti & Co. | Maintains | Buy → Buy | — | $15.53 | $15.64 | +0.7% | +1.8% | +0.4% | +13.4% | -1.0% | -1.3% |
| Nov 13 | Raymond James | Maintains | Outperform → Outperform | — | $15.53 | $15.64 | +0.7% | +1.8% | +0.4% | +13.4% | -1.0% | -1.3% |
| Mar 15 | Raymond James | Downgrade | Strong Buy → Outperform | — | $15.86 | $15.43 | -2.7% | -3.8% | -3.5% | -3.3% | -2.5% | -2.3% |
| Mar 14 | Raymond James | Downgrade | Strong Buy → Buy | — | $12.65 | $13.05 | +3.2% | +2.4% | -1.5% | -2.4% | +2.4% | +3.5% |
| Aug 22 | Jefferies | Upgrade | Hold → Buy | — | $8.60 | $9.00 | +4.7% | +14.8% | -4.8% | +4.3% | -1.0% | +1.0% |
| Nov 9 | Craig-Hallum | Downgrade | Buy → Hold | — | $6.80 | $5.67 | -16.7% | -5.9% | +3.9% | +2.3% | -2.9% | -3.0% |
| Jun 2 | Sterne Agee CRT | Maintains | Neutral → Neutral | — | $5.23 | $5.14 | -1.7% | +4.2% | -3.5% | +1.5% | +0.4% | +0.7% |
| Apr 15 | Sidoti & Co. | Maintains | Buy → Buy | — | $4.96 | $4.98 | +0.4% | +0.8% | +3.2% | +0.0% | +3.3% | +1.3% |
| Mar 15 | Jefferies | Maintains | Hold → Hold | — | $5.53 | $5.40 | -2.4% | -4.9% | +2.5% | -3.3% | +1.0% | -4.6% |
| Mar 26 | B. Riley FBR | Maintains | Buy → Buy | — | $7.77 | $8.16 | +5.0% | +5.7% | +0.2% | +3.0% | -0.9% | +3.3% |
| Date | Insider | Title | Type | Shares | Price | Value | Owned After | D1% | D5% |
|---|---|---|---|---|---|---|---|---|---|
| Jun 16, 2026 | Wesdorp CornelisOff | Pres & CEO, Digital Health | Sell | 4,750 | $58.11 | $276K | 69,075 | — | — |
| Jun 15, 2026 | Forthuber Stephen MOff | Pres & CEO-Eastern Operations | Sell | 19,853 | $58.61 | $1.2M | 507,199 | -6.53% | — |
| Jun 15, 2026 | Forthuber Stephen MOff | Pres & CEO-Eastern Operations | Sell | 24,214 | $57.79 | $1.4M | 527,052 | -6.53% | — |
8-K · 1.01
!! High
RadNet, Inc. -- 8-K 1.01: Material Agreement
RadNet amended its first lien credit agreement with an incremental amendment, increasing borrowing capacity and flexibility to support operations and potential growth initiatives.
Jun 10
8-K
RadNet, Inc. -- 8-K Filing
I cannot provide a meaningful analysis based on this summary, as it merely describes the filing format without disclosing material business information relevant to investors.
Jun 4
8-K · 8.01
!! High
RadNet, Inc. -- 8-K 8.01: Material Event / Announcement
RadNet secured a $200 million incremental term loan through an amendment to its credit facility, providing additional capital for growth or operational needs.
Jun 3
8-K · 2.02
!! High
RadNet, Inc. -- 8-K 2.02: Earnings Results
RadNet released Q1 2026 financial results, providing investors with updated performance metrics and operational information for the quarter ending March 31, 2026.
May 11
8-K · 7.01
! Medium
RadNet, Inc. -- 8-K 7.01: Regulation FD Disclosure
RadNet acquired French AI medical imaging company Gleamer for approximately €230 million through its subsidiary, expanding its diagnostic capabilities internationally.
Mar 2
8-K
RadNet, Inc. -- 8-K Filing
RadNet reported strong fourth-quarter 2025 results across its 418 imaging centers, with management expressing satisfaction with operational performance and positioning for continued growth.
Mar 2
Institutional (13F) — Top 20
All ↗
| # | Manager | Shares | Value | Chg | Period |
|---|---|---|---|---|---|
| 1 | Rtw Investments, Lp | 4,285,000 | $239M | Added | Mar 2026 |
| 2 | Vanguard Portfolio Management Llc | 3,899,127 | $218M | New | Mar 2026 |
| 3 | Beck Mack & Oliver Llc | 3,166,192 | $177M | Reduced | Mar 2026 |
| 4 | Vanguard Capital Management Llc | 3,111,012 | $174M | New | Mar 2026 |
| 5 | Morgan Stanley | 1,899,942 | $136M | Added | Dec 2025 |
| 6 | Invesco Ltd. | 1,633,495 | $91M | Added | Mar 2026 |
| 7 | Principal Financial Group Inc | 1,133,089 | $81M | Reduced | Dec 2025 |
| 8 | Jb Capital Partners Lp | 1,424,061 | $80M | — | Mar 2026 |
| 9 | Hood River Capital Management Llc | 1,411,497 | $79M | Added | Mar 2026 |
| 10 | Alyeska Investment Group, L.p. | 1,309,308 | $73M | Added | Mar 2026 |
| 11 | Clearbridge Investments, Llc | 1,278,540 | $71M | Added | Mar 2026 |
| 12 | Van Berkom & Associates Inc. | 1,028,586 | $57M | Added | Mar 2026 |
| 13 | Allspring Global Investments Holdings, Llc | 865,404 | $48M | Reduced | Mar 2026 |
| 14 | Point72 Asset Management | 855,372 | $48M | Added | Mar 2026 |
| 15 | Northern Trust Corp | 746,807 | $42M | Added | Mar 2026 |
| 16 | Rockefeller Capital Management L.p. | 703,116 | $39M | Added | Mar 2026 |
| 17 | Nuveen, Llc | 661,282 | $37M | Reduced | Mar 2026 |
| 18 | Global Alpha Capital Management Ltd. | 658,208 | $37M | Added | Mar 2026 |
| 19 | Bank Of America Corp /de/ | 589,610 | $33M | Added | Mar 2026 |
| 20 | Neuberger Berman Group Llc | 503,172 | $28M | Reduced | Mar 2026 |
Mutual Funds / ETFs (N-PORT) — Top 20
All ↗
Valuation
Market Cap
$4.04B
Enterprise Value
$4.34B
P/E (TTM)
-214.96x
Forward P/E
85.75x
PEG Ratio
0.38x
P/B
2.98x
P/S
1.98x
P/FCF
47.22x
EV/EBITDA
17.86x
Shares Out
75.2M
Financials (TTM)
Revenue
$2.04B
Net Income
-$18.7M
EBITDA
$242.9M
Free Cash Flow
$85.6M
Op Cash Flow
$298.8M
EPS Basic
$-0.25
EPS Diluted
$-0.25
EPS Forward
$0.63
Gross Margin
4.5%
Op Margin
4.5%
Net Margin
-0.9%
Balance Sheet
Total Assets
$3.76B
Total Liab.
$2.40B
Total Equity
$1.36B
Cash
$767.2M
LT Debt
$1.06B
Book Value/Sh
$18.03
Debt/Equity
1.71x
Current Ratio
1.76
Quick Ratio
1.76
Returns & Growth
ROE
-1.7%
ROA
-0.5%
ROIC
1.5%
Rev Growth YoY
+11.5%
EPS Growth YoY
-754.5%
Price Returns
2W
+3.9%
1M
-1.8%
3M
-20.5%
6M
-32.9%
12M
-3.4%
Technicals
52W High
$84.48
52W Low
$51.87
50d MA
$55.96
200d MA
$68.33
RSI (14)
45.60
ATR (14)
$2.76
Beta
1.53
Avg Volume
907K
Dividends
Div Rate
$0.00
Div Yield
—
Frequency
—
Ex-Div Date
—
Analyst Price Targets
Consensus
$92.00
High
$95.00
Low
$90.00
Median
$92.00
Data updated apr 26, 2026 10:14pm
· Source: financialmodelingprep.com